PKM and central nervous system cancer: Some studies have reported that PKM2 is overexpressed in glioma compared to control, while glioma‐adjacent tissues only showed a slight PKM2 overexpression, suggesting that PKM2 overexpression could be an important trigger for glioma progression [32].